Application of an Integrated Risk Matrix and the Borda Count Method on Lassa Fever in Assessing the Importation Risk of EID - 9 African Countries, 1996-2023

应用综合风险矩阵和博尔达计数法评估拉沙热输入性传染病风险——9个非洲国家,1996-2023年

阅读:1

Abstract

INTRODUCTION: Common methods for assessing and responding to outbreaks of emerging infectious diseases (EIDs) are usually applied in isolation and have limitations. This study aimed to integrate the risk matrix and Borda count methods to assess the importation risk of EIDs to China, using Lassa fever (LF) as an example. METHODS: This study used a mixed-methods approach combining multi-source data with an integrated risk matrix and Borda count method. Data were obtained from the World Health Organization, the Concise Statistics of International Students dataset, the United Nations World Tourism Organization, and the Statistical Yearbook. Importation risk was assessed across two dimensions: possibility and severity. Total importation risk was then categorized into 4 levels (low, moderate, high, and extremely high), corresponding to green, yellow, orange, and red zones, respectively, in the risk matrix assessment index. The Borda count method was used to rank the risks. RESULTS: The importation risk for 9 countries that experienced LF outbreaks from 1996 to 2023 was scored and ranked by importation possibility and severity to derive overall importation risks. This study determined that Nigeria posed the highest LF importation risk to China, ranking first among West African countries with the highest Borda points. Countries with moderate importation risk included Sierra Leone, Burkina Faso, and Ghana. DISCUSSION: An integrated risk matrix and Borda count method presented in this study may serve as a significant supplement to other risk assessment methods and enrich the current toolbox of public health countermeasures and inform future risk management of the importation of EIDs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。